Rotavirus vaccination in developing countries

Current Opinion in Virology

Volumn 2, Issue 4, 2012, Pages 443-448

  Babji, Sudhir ^a   Kang, Gagandeep ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; ROTAVIRUS VACCINE; SECRETORY IMMUNOGLOBULIN; TOLL LIKE RECEPTOR;

ARTICLE; DEVELOPING COUNTRY; DRUG EFFICACY; GASTROENTERITIS; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; IMMUNITY; IMMUNOGENICITY; INTUSSUSCEPTION; LOWEST INCOME GROUP; MALNUTRITION; MORTALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOL DEFICIENCY; ROTAVIRUS INFECTION; TREATMENT RESPONSE; VACCINATION; VIRUS LIKE AGENT; VIRUS REPLICATION; VITAMIN D DEFICIENCY; ZINC DEFICIENCY;

EID: 84865137295     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.05.005     Document Type: Review

References (55)

1. J.E. Tate, A.H. Burton, C. Boschi-Pinto, A.D. Steele, J. Duque, and U.D. Parashar 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis Lancet Infectious Diseases 12 2012 136 141 The most recent update of rotavirus mortality estimates, using studies with a mid-point of data collection in 2000 and after, intended to provide a baseline before widespread vaccine inroduction. The data show a decrease in estimates, largely because of decreased diarrheal mortality reports from India and China.
2. J.E. Tate, M.M. Patel, M.M. Cortese, B.A. Lopman, J.R. Gentsch, J. Fleming, A.D. Steele, and U.D. Parashar Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality Expert Review of Vaccines 11 2012 211 220
3. V. Richardson, U. Parashar, and M. Patel Childhood diarrhea deaths after rotavirus vaccination in Mexico New England Journal of Medicine 365 2011 772 773
4. Rotavirus vaccines: an update. Weekly Epidemiological Record 2009:533-540.
5. T. Vesikari, D.O. Matson, P. Dennehy, P. Van Damme, M. Santosham, Z. Rodriguez, M.J. Dallas, J.F. Heyse, M.G. Goveia, and S.B. Black Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine New England Journal of Medicine 354 2006 23 33 (Pubitemid 43048948)
6. G.M. Ruiz-Palacios, I. Perez-Schael, F.R. Velazquez, H. Abate, T. Breuer, S.C. Clemens, B. Cheuvart, F. Espinoza, P. Gillard, and B.L. Innis Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis New England Journal of Medicine 354 2006 11 22 (Pubitemid 43048947)
7. K.B. Phua, F.S. Lim, Y.L. Lau, E.A. Nelson, L.M. Huang, S.H. Quak, B.W. Lee, Y.L. Teoh, H. Tang, and I. Boudville Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study Vaccine 27 2009 5936 5941
8. K. Zaman, D.A. Dang, J.C. Victor, S. Shin, M. Yunus, M.J. Dallas, G. Podder, D.T. Vu, T.P. Le, and S.P. Luby Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial Lancet 376 2010 615 623 A multi-centre, randomized placebo-controlled trial of oral pentavelent rotavirus vaccine given with routine immunization at 6, 10 and 14 weeks in Bangladesh and Vietnam showed a vaccine efficacy of 48.3% over two years of follow up.
9. S.A. Madhi, N.A. Cunliffe, D. Steele, D. Witte, M. Kirsten, C. Louw, B. Ngwira, J.C. Victor, P.H. Gillard, and B.B. Cheuvart Effect of human rotavirus vaccine on severe diarrhea in African infants New England Journal of Medicine 362 2010 289 298 A multi-centre, randomized placebo controlled trial of an oral monvalent rotavirus vaccine in South Africa and Malawi showed a vaccine efficacy of 61.2% over one year of follow up.
10. G.E. Armah, S.O. Sow, R.F. Breiman, M.J. Dallas, M.D. Tapia, D.R. Feikin, F.N. Binka, A.D. Steele, K.F. Laserson, and N.A. Ansah Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial Lancet 376 2010 606 614 Multi-centre randomized placebo-controlled trial of oral pentavalent rotavirus vaccine in Ghana, Kenya and Mali showed a vaccine efficacy of 39.3% over 21 months of follow up.
11. P. Hanlon, L. Hanlon, V. Marsh, P. Byass, F. Shenton, M. Hassan-King, O. Jobe, H. Sillah, R. Hayes, and B.H. M'Boge Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants Lancet 1 1987 1342 1345 (Pubitemid 17076248)
12. M. Patel, A.L. Shane, U.D. Parashar, B. Jiang, J.R. Gentsch, and R.I. Glass Oral rotavirus vaccines: how well will they work where they are needed most? Journal of Infectious Diseases 200 Suppl. 1 2009 S39 S48 A review demonstrating that oral rotavirus vaccines have lower immunogenicity in low income countries. Although immunogenicity is measured as anti-rotavirus IgA, there is no correlate of protection and serum IgA alone does not predict efficacy.
13. N.C. Grassly, C. Fraser, J. Wenger, J.M. Deshpande, R.W. Sutter, D.L. Heymann, and R.B. Aylward New strategies for the elimination of polio from India Science 314 2006 1150 1153 (Pubitemid 44789046)
14. R. Desai, L.H. Oliveira, U.D. Parashar, B. Lopman, J.E. Tate, and M.M. Patel Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America: a review Memorias do Instituto Oswaldo Cruz 106 2011 907 911 Studies from Latin America are reviewed to demonstrate the impact on disease and nortality. A decrease in deaths, severe rotavirus disease and in all-cause diarrhea was seen in all countries, but with demonstrably lower effectiveness in Nicaragua, the only low-income country in the region.
15. O. de Palma, L. Cruz, H. Ramos, A. de Baires, N. Villatoro, D. Pastor, L.H. de Oliveira, T. Kerin, M. Bowen, and J. Gentsch Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study British Medical Journal 340 2010 c2825
16. G.M. do Carmo, C. Yen, J. Cortes, A.A. Siqueira, W.K. de Oliveira, J.J. Cortez-Escalante, B. Lopman, B. Flannery, L.H. de Oliveira, and E.H. Carmo Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis PLoS Medicine 8 2011 e1001024
17. J.J. Amador, J. Vasquez, M. Orozco, C. Pedreira, O. Malespin, L.H. De Oliveira, J. Tate, U. Parashar, and M. Patel Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program International Journal of Infectious Diseases 14 2010 e592 e595
18. S.A. Wilopo, P. Kilgore, S. Kosen, Y. Soenarto, S. Aminah, A. Cahyono, M. Ulfa, and A. Tholib Economic evaluation of a routine rotavirus vaccination programme in Indonesia Vaccine 27 Suppl. 5 2009 F67 F74
19. D.H. Esposito, J.E. Tate, G. Kang, and U.D. Parashar Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008 Clinical Infectious Diseases 52 2011 171 177
20. J. Rose, R.L. Hawthorn, B. Watts, and M.E. Singer Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis British Medical Journal 339 2009 b3653
21. H. Khoury, I. Ogilvie, A.C. El Khoury, Y. Duan, and M.M. Goetghebeur Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population BMC Infectious Diseases 11 2011 9
22. S.A. Berry, B. Johns, C. Shih, A.A. Berry, and D.G. Walker The cost-effectiveness of rotavirus vaccination in Malawi Journal of Infectious Diseases 202 Suppl. 2010 S108 S115
23. M.L. Arvay, A.T. Curns, S. Terp, G. Armah, P. Wontuo, U.D. Parashar, F. Binka, R.I. Glass, and M.A. Widdowson How much could rotavirus vaccines reduce diarrhea-associated mortality in northern Ghana? A model to assess impact Journal of Infectious Diseases 200 Suppl. 1 2009 S85 S91
24. J.E. Tate, A. Kisakye, P. Mugyenyi, D. Kizza, A. Odiit, and F. Braka Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda Vaccine 29 2011 3329 3334
25. J.E. Tate, R.D. Rheingans, C.E. O'Reilly, B. Obonyo, D.C. Burton, J.A. Tornheim, K. Adazu, P. Jaron, B. Ochieng, and T. Kerin Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya Journal of Infectious Diseases 200 Suppl. 1 2009 S76 S84
26. J.E. Tate, S. Chitambar, D.H. Esposito, R. Sarkar, B. Gladstone, S. Ramani, M.V. Raghava, T.V. Sowmyanarayanan, S. Gandhe, and R. Arora Disease and economic burden of rotavirus diarrhoea in India Vaccine 27 Suppl. 5 2009 F18 F24
27. A.S. Mendelsohn, J.R. Asirvatham, D. Mkaya Mwamburi, T.V. Sowmynarayanan, V. Malik, J. Muliyil, and G. Kang Estimates of the economic burden of rotavirus-associated and all-cause diarrhoea in Vellore, India Tropical Medicine and International Health 13 2008 934 942 (Pubitemid 351813521)
28. E. Simpson, S. Wittet, J. Bonilla, K. Gamazina, L. Cooley, and J.L. Winkler Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries BMC Public Health 7 2007 281
29. T.V. Murphy, P.M. Gargiullo, M.S. Massoudi, D.B. Nelson, A.O. Jumaan, C.A. Okoro, L.R. Zanardi, S. Setia, E. Fair, and C.W. LeBaron Intussusception among infants given an oral rotavirus vaccine New England Journal of Medicine 344 2001 564 572 (Pubitemid 32167870)
30. I.M. Shui, J. Baggs, M. Patel, U.D. Parashar, M. Rett, E.A. Belongia, S.J. Hambidge, J.M. Glanz, N.P. Klein, and E. Weintraub Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants The Journal of the American Medical Association 307 2012 598 604
31. J.P. Buttery, M.H. Danchin, K.J. Lee, J.B. Carlin, P.B. McIntyre, E.J. Elliott, R. Booy, and J.E. Bines Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia Vaccine 29 2011 3061 3066
32. M.M. Patel, V.R. Lopez-Collada, M.M. Bulhoes, L.H. De Oliveira, A. Bautista Marquez, B. Flannery, M. Esparza-Aguilar, E.I. Montenegro Renoiner, M.E. Luna-Cruz, and H.K. Sato Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil New England Journal of Medicine 364 2011 2283 2292
33. M. Ustrup, L.B. Madsen, I.C. Bygbjerg, and F. Konradsen Outstanding challenges for rotavirus vaccine introduction in low-income countries - a systematic review Danish Medical Bulletin 58 2011 A4323
34. D. Sinclair, K. Abba, K. Zaman, F. Qadri, and P.M. Graves Oral vaccines for preventing cholera Cochrane Database of Systematic Reviews 2011 CD008603
35. H. Okayasu, R.W. Sutter, C. Czerkinsky, and P.L. Ogra Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission Vaccine 29 2011 8205 8214
36. A.C. Serazin, L.A. Shackelton, C. Wilson, and M.K. Bhan Improving the performance of enteric vaccines in the developing world Nature Immunology 11 2010 769 773 A report of a meeting organized by the Bill and Melinda Gates Foundation in 2010 reviewed the potential causes for under performance of enteric vaccines in developing countries.
37. D. Kim, and S. Niewiesk Sidestepping maternal antibody: a lesson from measles virus vaccination Expert Review of Clinical Immunology 7 2011 557 559
38. P. Brandtzaeg Function of mucosa-associated lymphoid tissue in antibody formation Immunological Investigations 39 2010 303 355
39. N.H. Salzman, M.A. Underwood, and C.L. Bevins Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa Seminars in Immunology 19 2007 70 83 (Pubitemid 46824070)
40. L.V. Thomas, and T. Ockhuizen New insights into the impact of the intestinal microbiota on health and disease: a symposium report British Journal of Nutrition 107 Suppl. 1 2012 S1 S13
41. A.D. Steele, M. Patel, U.D. Parashar, J.C. Victor, T. Aguado, and K.M. Neuzil Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation Journal of Infectious Diseases 200 Suppl. 1 2009 S63 S69
42. N. Bhandari, P. Sharma, R.I. Glass, P. Ray, H. Greenberg, S. Taneja, M. Saksena, C.D. Rao, J.R. Gentsch, and U. Parashar Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial Vaccine 24 2006 5817 5823 (Pubitemid 43947390)
43. J.S. Bresee, U.D. Parashar, M.A. Widdowson, J.R. Gentsch, A.D. Steele, and R.I. Glass Update on rotavirus vaccines Pediatric Infectious Disease Journal 24 2005 947 952 (Pubitemid 41689595)
44. P. Bhaskaram, K.M. Nair, P. Hemalatha, N. Murthy, and P. Nair Systemic and mucosal immune response to polio vaccination with additional dose in newborn period Journal of Tropical Pediatrics 43 1997 232 234 (Pubitemid 27370968)
45. M.J. Albert, F. Qadri, M.A. Wahed, T. Ahmed, A.S. Rahman, F. Ahmed, N.A. Bhuiyan, K. Zaman, A.H. Baqui, and J.D. Clemens Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine Journal of Infectious Diseases 187 2003 909 913 (Pubitemid 36337903)
46. B.P. Gladstone, S. Ramani, I. Mukhopadhya, J. Muliyil, R. Sarkar, A.M. Rehman, S. Jaffar, M.I. Gomara, J.J. Gray, and D.W. Brown Protective effect of natural rotavirus infection in an Indian birth cohort New England Journal of Medicine 365 2011 337 346
47. G. Kang, R. Arora, S.D. Chitambar, J. Deshpande, M.D. Gupte, M. Kulkarni, T.N. Naik, D. Mukherji, S. Venkatasubramaniam, and J.R. Gentsch Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years Journal of Infectious Diseases 200 Suppl. 1 2009 S147 S153
48. T.J. Gill 3rd, C.F. Repetti, L.A. Metlay, B.S. Rabin, F.H. Taylor, D.S. Thompson, and A.L. Cortese Transplacental immunization of the human fetus to tetanus by immunization of the mother Journal of Clinical Investigation 72 1983 987 996 (Pubitemid 14212616)
49. D.R. Snodgrass, K.J. Fahey, P.W. Wells, I. Campbell, and A. Whitelaw Passive immunity in calf rotavirus infections: maternal vaccination increases and prolongs immunoglobulin G1 antibody secretion in milk Infection and Immunity 28 1980 344 349 (Pubitemid 10102065)
50. H. Zhou, L. Guo, M. Wang, J. Qu, Z. Zhao, J. Wang, and T. Hung Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice Virology Journal 8 2011 3
51. M.A. Franco, J. Angel, and H.B. Greenberg Immunity and correlates of protection for rotavirus vaccines Vaccine 24 2006 2718 2731
52. U. Desselberger, and H.I. Huppertz Immune responses to rotavirus infection and vaccination and associated correlates of protection Journal of Infectious Diseases 203 2011 188 195
53. M.M. McNeal, R.L. Broome, and R.L. Ward Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination Virology 204 1994 642 650 (Pubitemid 24330869)
54. S.E. Crawford, M.K. Estes, M. Ciarlet, C. Barone, C.M. O'Neal, J. Cohen, and M.E. Conner Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles Journal of Virology 73 1999 4813 4822 (Pubitemid 29246741)
55. B. Jiang, M.K. Estes, C. Barone, V. Barniak, C.M. O'Neal, A. Ottaiano, H.P. Madore, and M.E. Conner Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles Vaccine 17 1999 1005 1013 (Pubitemid 29074757)